[1]
A. R. Schlösser, “Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study”, Acta Derm Venereol, vol. 105, p. adv44165, Nov. 2025.